4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jinhai Medical Technology Limited (2225) operates in the Conglomerates industry and is headquartered in Wan Chai, Hong Kong with about 472 employees. Its market capitalization is roughly HK$33 billion. In the fiscal year ended 2025-12-31, 2225 reported SGD 46M in revenue and (SGD 17M) in net income.
Jinhai Medical Technology Limited, an investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore. It also offers manpower outsourcing and ancillary services to building and construction contractors.
Interactive charts & full statements → Open the 2225 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | SGD 46M | SGD 50M | SGD 46M | SGD 22M | — |
| Gross Profit | SGD 7M | SGD 12M | SGD 12M | SGD 10M | — |
| Operating Income (EBIT) | (SGD 18M) | (SGD 20M) | (SGD 4M) | SGD 0M | — |
| Net Income | (SGD 17M) | (SGD 18M) | (SGD 3M) | SGD 0M | — |
SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | SGD 89M | SGD 59M | SGD 62M | SGD 40M | — |
| Total Liabilities | SGD 37M | SGD 26M | SGD 25M | SGD 16M | — |
SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2225 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms